受忽视群体仍被忽视:入组标准常规将其排除在乳腺癌试验之外
该研究检索了2010年1月1日至2020年12月31日高影响力期刊上发表的乳腺癌III期随机对照试验,共返回5133项合格试验,简单随机选取40项分析其入排标准。结果显示全部40项试验均存在多重排除,影响受忽视群体的招募;40项试验中有39项对入排标准的临床或科学理由报告不足。作者认为试验入选标准将受忽视群体排除在乳腺癌试验之外,建议试验者提供每项入选标准的理由,且资助方、审稿人、伦理委员会等应要求提供理由。
要点
- 全部40项乳腺癌III期试验均存在多重排除,影响受忽视群体招募。
- 40项试验中有39项对入排标准的临床或科学理由报告不足。
- 作者建议试验者为每项入选标准提供理由,资助方等应要求提供。
核心结论
- 临床试验入选标准将受忽视群体排除在乳腺癌试验之外。
- 作者建议试验者为每项入选标准提供理由,资助方、审稿人、伦理委员会等应要求提供理由。
- 否则受忽视群体将继续处于受忽视状态。
研究设计与样本
- 研究检索Medline中2010年1月1日至2020年12月31日高影响力期刊发表的评估乳腺癌干预药物的III期随机对照试验。
- 共返回5133项合格试验,通过简单随机选取40项纳入分析。
主要发现
- 全部40项试验均存在多重排除,影响受忽视群体的招募。
- 40项试验中有39项对记录的入排标准的临床或科学理由报告不足。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Under-served groups are populations unrepresented or disengaged from medical research or services despite a disproportionately high healthcare burden. Under-served groups may be directly (age, pregnancy as examples) or indirectly excluded (provision of written information in one language only as an example) from trial enrollment by strict eligibility exclusions. The purpose of our study was to assess eligibility criteria in published phase III breast cancer clinical trials to determine whether they excluded underserved groups either directly or indirectly. STUDY DESIGN AND SETTING: Medline was searched for phase III randomized controlled trials evaluating interventional drugs for breast cancer in high-impact journals published between January 1st, 2010 and December 31st, 2020. A total of 5133 eligible trials were returned, and 40 were selected, by simple randomization, for inclusion. RESULTS: All 40 trials had multiple exclusions that affected the recruitment of underserved groups. Clinical or scientific rationale for the recorded inclusion and exclusion criteria was underreported in 39 of 40 trials. CONCLUSION: Clinical trial eligibility criteria exclude underserved groups from breast cancer trials. Trialists should provide a justification for each eligibility criterion, and funders, reviewers, ethics committees, and others should demand one. Without this, underserved groups will remain just that: underserved.
引用
- Moloney C, Shiely F. Underserved groups remain underserved as eligibility criteria routinely exclude them from breast cancer trials. J Clin Epidemiol. 2022. PMID: 35341945. doi:10.1016/j.jclinepi.2022.03.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。